Oragenics, Inc. (OGEN)
AMEX·Healthcare·Biotechnology
$0.61
-3.17%
Mkt Cap $4.00M
EPS — Estimate vs Actual
Revenue — Estimate vs Actual
Quarterly History
| Q1 2026 Feb 26, 2026 | — | — | — | -$90.00 | -$0.54 | +99.40% | — | — |
| Q4 2025 Nov 7, 2025 | — | — | — | — | -$1.96 | — | — | — |
| Q3 2025 Aug 8, 2025 | — | — | — | — | -$3.10 | — | — | — |
| Q2 2025 May 9, 2025 | — | — | — | — | -$3.60 | — | — | — |
| Q1 2025 Mar 14, 2025 | — | — | — | — | -$0.11 | — | — | — |
| Q4 2024 Nov 13, 2024 | — | — | — | — | -$0.38 | — | — | — |
| Q3 2024 Aug 9, 2024 | — | — | — | — | -$0.51 | — | — | — |
| Q1 2024 Mar 29, 2024 | — | -$37.65K | — | -$3.00 | -$5.48 | -82.67% | — | — |
| Q4 2023 Nov 9, 2023 | — | $7.47K | — | -$3.00 | -$0.85 | +71.67% | — | — |
| Q3 2023 Aug 14, 2023 | — | $13.16K | — | -$3.00 | -$1.51 | +49.67% | — | — |
| Q2 2023 May 12, 2023 | — | — | — | -$3.00 | -$1.41 | +53.00% | — | — |
| Q1 2023 Mar 29, 2023 | — | $131.52K | — | -$2.40 | -$0.12 | +94.94% | — | — |
| Q4 2022 Nov 14, 2022 | — | $86.05K | — | -$3.00 | -$1.80 | +40.00% | — | — |
| Q3 2022 Aug 9, 2022 | — | $30.39K | — | -$1.44 | -$1.80 | -25.00% | — | — |
| Q2 2022 May 13, 2022 | — | $15.08K | — | -$1.20 | -$2.99 | -150.00% | — | — |
| Q1 2022 Mar 24, 2022 | — | $86.99K | — | -$0.80 | -$1.20 | -50.00% | — | — |
| Q4 2021 Nov 15, 2021 | — | — | — | -$0.00 | -$2.40 | -358108.96% | — | — |
| Q3 2021 Aug 16, 2021 | — | — | — | -$1.44 | -$1.80 | -25.00% | — | — |
| Q2 2021 May 3, 2021 | — | — | — | -$2.69 | -$2.99 | -11.11% | — | — |
| Q1 2021 Mar 2, 2021 | — | — | — | -$3.59 | -$2.99 | +16.71% | — | — |